2Nazarali AJ, Reynolds GP. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmoterm study. Cell Mol Neurobiol, 1992,12:581
3Rossor MN, Iversen LL, Reynolds GG, et al. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J, 1984,258:961
4Palmer AM. Neurochemical studies of Alzheimer's disease. Neurodegeneration, 1996,5: 381
6Sheline YI, Miller K, Bardgett ME, et al. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction. Am J Geriatr Psyhiatry, 1998,6: 155
7Meneses A. Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory. Rev Neurosci, 1998,9:275
8Cotman CW,Anderson AJ.A potential role for apoptosis in neuro-degeneration and Alzheimer's disease.Mol Neurobiol, 1995,10:19
9Itoh A, Nitta A, Nadai M, et al. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein-infused rats. J Neurochem, 1996, 66:1113
